Wednesday, July 8, 2026

biotech · Huntington Disease · Alzheimer Disease · VYGR

Voyager Therapeutics

Voyager Therapeutics trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Lexington, USA HQ
2014 Founded
168 Employees
Public company Type
VYGR · NYSE Ticker
Company details
Status
Public
HQ
Lexington, USA
Founded
2014
Employees
168
Programs
4
Drugs
4
Patents
31
Intelligence · Clinical Trials

Voyager Therapeutics clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to Voyager Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Voyager Therapeutics trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Voyager Therapeutics.

  1. Leuprolide acetate — Phase 2

    Clinical update
  2. Intraparenchymal rAAV1 - (mi)RNA HTT — Phase 1

    Clinical update
  3. VY7523 — Phase 2

    Clinical update
  4. VP4896 — Phase 3

    Clinical update

Trial registry

5 studies